Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Registration for Controlled Substances Act Data-Use Request, 94763-94764 [2024-28045]

Download as PDF Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on August 22, 2024, Curia Wisconsin, Inc., 870 Badger Circle, Grafton, Wisconsin 53024–9436, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance Gamma Hydroxybutyric Acid. Marihuana Extract .... Marihuana ................. Dimethyltryptamine ... Drug code Schedule 2010 I 7350 7360 7435 I I I The company plans to import the listed controlled substances for analytical testing or distribution. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–28063 Filed 11–27–24; 8:45 am] BILLING CODE P Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 30, 2024. Such persons may also file a written request for a hearing on the application on or before December 30, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on June 18, 2024, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616–3466, applied to be registered as an importer of the following basic class(es) of controlled substance(s): DATES: DEPARTMENT OF JUSTICE Controlled substance Drug Enforcement Administration Psilocybin ........................ 4-Anilino-N-phenethyl-4piperidine (ANPP). Phenylacetone ................. Coca Leaves ................... Opium Raw ...................... Poppy Straw Concentrate [Docket No. DEA–1460] Importer of Controlled Substances Application: Cambrex Charles City Drug Enforcement Administration, Justice. ACTION: Notice of application. khammond on DSK9W7S144PROD with NOTICES AGENCY: Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. SUMMARY: VerDate Sep<11>2014 21:22 Nov 27, 2024 Jkt 265001 Drug code Schedule 7437 8333 I II 8501 9040 9600 9670 II II II II The company plans to import psilocybin for formulation development and clinical trial support for their customers. The remaining listed controlled substances will be imported to support the manufacture into other controlled substances which will be PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 94763 distributed to their customers. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–28064 Filed 11–27–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE [OMB Number 1117–0059] Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Registration for Controlled Substances Act Data-Use Request Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until December 30, 2024. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Heather E. Achbach, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776–3882; Email: DEA.PRA@dea.gov or Heather.E.Achbach@dea.gov. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on September 24, 2024, at 89 FR 77895, allowing for a 60-day comment period. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should SUMMARY: E:\FR\FM\29NON1.SGM 29NON1 94764 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices khammond on DSK9W7S144PROD with NOTICES address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the information collection or the OMB Control Number 1117–0059. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view Department of Justice, information collections currently under review by OMB. DOJ seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOJ notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. Overview of This Information Collection: 1. Type of Information Collection: Extension of a previously approved collection. 2. Title of the Form/Collection: Registration for CSA Data-Use Request. 3. Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: No form number is associated with this collection. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. VerDate Sep<11>2014 21:22 Nov 27, 2024 Jkt 265001 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, Local, and tribal governments. 5. Abstract: In accordance with the Controlled Substance Act (CSA), every person who manufactures, distributes, dispenses, conducts research with, imports, or exports any controlled substance to obtain a registration issued by the Attorney General. 21 U.S.C. 822, 823, and 957. While DEA registrants are able to self-verify their registration status, non-registrants do not have an obligation to register under the CSA, and therefore does not have an automatic means to verify the registration of a DEA-registrant. Nonregistrants have obligations to verify the registration statuses before doing things such as hiring practitioners, paying for controlled substance prescriptions covered by Medicaid or Medicare, and other means that are apart of commerce. This proposed collection would allow non-registrants to register for access to the CSA Database System, which gives the names and registration statuses of all DEA-registrants. Applicants would be required to re-apply annually by completing this form and submitting to DEA. 6. Obligation to Respond: Required to obtain or retain benefits. 7. Total Estimated Number of Respondents: 9,000. 8. Estimated Time per Respondent: 15 minutes. 9. Frequency: 1 per year. 10. Total Estimated Annual Time Burden: 2,250 hours. 11. Total Estimated Annual Other Costs Burden: $0. If additional information is required, contact: Darwin Arceo, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, United States Department of Justice, Two Constitution Square, 145 N Street NE, 4W–218 Washington, DC 20530. Dated: November 25, 2024. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2024–28045 Filed 11–27–24; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE [OMB Number 1125–0010] Agency Information Collection Activities; Proposed eCollection; eComments Requested; Extension of a Previously Approved Collection; Notice of Appeal to the Board of Immigration Appeals From a Decision of a DHS Officer (EOIR–29) Executive Office for Immigration Review, Department of Justice. ACTION: 30-Day notice. AGENCY: The Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until December 30, 2024. FOR FURTHER INFORMATION CONTACT: The proposed information collection was previously published in the Federal Register on September 13, 2024, 89 FR 76510, allowing a 60 day-comment period. If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Zach Leciejewski, Attorney Advisor, Executive Office for Immigration Review, 5107 Leesburg Pike, Suite 2500, Falls Church, VA 22041, phone (703) 305–0990 or email eoir.pra.comments@ usdoj.gov or Zach.Leciejewski@ usdoj.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and SUMMARY: E:\FR\FM\29NON1.SGM 29NON1

Agencies

[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94763-94764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28045]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0059]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Extension of a Previously Approved Collection; 
Registration for Controlled Substances Act Data-Use Request

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995.

DATES: Comments are encouraged and will be accepted for 30 days until 
December 30, 2024.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Heather E. 
Achbach, Regulatory Drafting and Policy Support Section, Drug 
Enforcement Administration; Mailing Address: 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email: 
[email protected] or [email protected].

SUPPLEMENTARY INFORMATION: This proposed information collection was 
previously published in the Federal Register on September 24, 2024, at 
89 FR 77895, allowing for a 60-day comment period. Written comments and 
suggestions from the public and affected agencies concerning the 
proposed collection of information are encouraged. Your comments should

[[Page 94764]]

address one or more of the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website www.reginfo.gov/public/do/PRAMain. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number 1117-0059. This information collection request 
may be viewed at www.reginfo.gov. Follow the instructions to view 
Department of Justice, information collections currently under review 
by OMB.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.

Overview of This Information Collection:

    1. Type of Information Collection: Extension of a previously 
approved collection.
    2. Title of the Form/Collection: Registration for CSA Data-Use 
Request.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: No form number is 
associated with this collection. The applicable component within the 
Department of Justice is the Drug Enforcement Administration, Diversion 
Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, Local, and tribal governments.
    5. Abstract: In accordance with the Controlled Substance Act (CSA), 
every person who manufactures, distributes, dispenses, conducts 
research with, imports, or exports any controlled substance to obtain a 
registration issued by the Attorney General. 21 U.S.C. 822, 823, and 
957. While DEA registrants are able to self-verify their registration 
status, non-registrants do not have an obligation to register under the 
CSA, and therefore does not have an automatic means to verify the 
registration of a DEA-registrant. Non-registrants have obligations to 
verify the registration statuses before doing things such as hiring 
practitioners, paying for controlled substance prescriptions covered by 
Medicaid or Medicare, and other means that are apart of commerce. This 
proposed collection would allow non-registrants to register for access 
to the CSA Database System, which gives the names and registration 
statuses of all DEA-registrants. Applicants would be required to re-
apply annually by completing this form and submitting to DEA.
    6. Obligation to Respond: Required to obtain or retain benefits.
    7. Total Estimated Number of Respondents: 9,000.
    8. Estimated Time per Respondent: 15 minutes.
    9. Frequency: 1 per year.
    10. Total Estimated Annual Time Burden: 2,250 hours.
    11. Total Estimated Annual Other Costs Burden: $0.
    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.

    Dated: November 25, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-28045 Filed 11-27-24; 8:45 am]
BILLING CODE 4410-09-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.